Search Results for “FDA” – Page 167 – media

Viz.ai Develops AI Software to Detect Stroke

Artificial intelligence based company Viz.ai, currently developing software for the detection of urgent stroke cases, has recently raised $21 million in venture capital to develop its portfolio.
- Source: FierceBiotech
- 822
- July 20, 2018
AI Company Insight digital health FDA
Genetic Disorder Cured in Utero Using Gene-Editing Technique

In what seems to be a first of its kind research, Carnegie Mellon University and Yale University researchers have successfully cured a genetic condition in a mouse model with a gene editing technique. The findings of the study showcase a potential new opportunity for further research into treating genetic disorders in utero.
- Source: drugdu
- 478
- July 19, 2018
gene editing Researches
Electrocore Releases Gammacore Therapy against Migraine and Episodic Cluster Headaches

ElectroCore, famous for bioelectronic medicines, is associating with UpScriptHealth to deliver its gammaCore treatment via direct-to-patient telemedicine program. This non-invasive stimulation therapy of vagus nerve is used to treat migraines and episodic cluster headaches among the adults.
- Source: FierceBiotech
- 770
- July 19, 2018
biotech cluster headache medtech migraine New Approvals
Recent Study Reports on Liver Cancer Risks and Detection

HCC or hepatocellular carcinoma can result in patients getting liver diseases such as viral hepatitis and non-alcoholic fatty liver disease with cirrhosis due to disease progression. New data from recent researches shows factors that improve early detection and diagnosis, and risks prior to HCC and during treatment.
- Source: Healio
- 565
- July 19, 2018
liver cancer Researches
Spero Gets Grant of $54M for Biodefense R&D for SPR994

Spero Therapeutics granted $15.7 million for research on SPR994, its oral carbapenem-class candidate, to study the drug’s efficacy against biological threats like anthrax, plague and melioidosis as a part of an interagency collaboration.
- Source: FierceBiotech
- 806
- July 18, 2018
biotech Company Insight
Red Wine and Green Tea could Treat Congenital Inborn Metabolic Diseases

A research team from Tel Aviv University suggested that red wine and green tea could treat certain congenital metabolic diseases, by blocking toxic metabolite formations. Since people with inborn metabolic disorders are born with a defective gene, it leads to a critical enzyme deficiency. Since there is no cure, many patients with congenital metabolic disorders are required to follow a lifelong strict diet.
- Source: Science Daily
- 549
- July 10, 2018
metabolic disease Researches
PharmaAsia Recap

Recent news regarding pharma companies in Asia
- Source: FiercePharma
- 733
- July 3, 2018
Asia Market Views pharmaceutical company
Biotech Crinetics Therapeutics Raises $86 million in IPO

The San Diego-based biotech company Crinetics Therapeutics recently raised $86 million in an IPO. Prior to the new funding, the company received $63.5 million in series B funding and will see its lead asset through phase 2.
- Source: FierceBiotech
- 797
- June 26, 2018
biotech Clinical Trials endocrine disorders
Indian Healthcare Startup SigTuple Raised $19 Million AI Based Products Development

India, Bengaluru based SigTuple, a startup focusing on Artificial Intelligence for Healthcare has raised $19 million in their series B funding. The investment was led by IDG Ventures, pi Ventures Partners along with Accel, Axilor Ventures, VH Capital, Endiya Partners and Flipkart’s executive chairman Binny Bansal. The startup has also bagged venture debt from Trifecta Capital in this round. In an earlier investment round, the company raised $6.5 million from various investors.
- Source: Analytics India
- 708
- June 26, 2018
AI Company Insight digital health start ups
Glaukos Corporation to receive Pre-Market approval for Next-Gen iStent

The inject is developed to achieve the natural outflow of aqueous humor by making two patent bypasses through the trabecular meshwork, glaucomatous eyes the main source of resistance resulting in multi-directional flow through Schlemm’s canal
- Source: BioSpectrumAsia
- 554
- June 26, 2018
FDA medtech New Approvals Optometry

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.